Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-12-14 to 2023-01-04
Current total value of award: $8471.43
Description: 4559382550!TOCILIZUMAB 162MG/.9 1